Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nadroparin for prevention of catheter-related deep vein thrombosis in hemato-oncology patients receiving high-dose chemotherapy
NL-OMON21969Active, not recruiting
- Sponsor
- Academic Medical Center
- Start
- Apr 2002
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial in deep vein thrombosis (DVT) comparing Nadroparin with Placebo (2 arms). Primary endpoint: Asymptomatic and symptomatic catheter-related deep vein thrombosis. Started Apr 2002; status: active, not recruiting.
02
Drugs
nadroparin
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NL-OMON21969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21969.